20
Participants
Start Date
January 1, 2021
Primary Completion Date
June 30, 2023
Study Completion Date
June 30, 2023
Continuous venovenous hemodiafiltration with high adsorption membrane (oXiris®)
CRRT initiation will be determined by the treating physician on charge, according with the current recommendations of clinical practice and prescriptions of CRRT and local management protocols. The CVVHDF mode will be performed by using PrismafleX eXeed™ system and high adsorbent polyethyleneimide membrane (oXiris®). Filtration parameters will be determined following the local protocol (dose of 25-30 ml/kg/h).
Antibiotics
Antibiotic concentration-time data will be collected and analyzed.
Helena Colom Codina, Barcelona
Baxter Healthcare Corporation
INDUSTRY
Hospital Universitari de Bellvitge
OTHER